Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84) | Zendy

Kristina Chen | Zendy; Elvira O. Gosmanova | Zendy; Gary C. Curhan | Zendy; Markus Ketteler | Zendy; Mishaela R. Rubin | Zendy; Elyse Swallow | Zendy; Jing Zhao | Zendy; Jessie Wang | Zendy; Nicole Sherry | Zendy; Alan Krasner | Zendy; John P. Bilezikian | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1–84)

Author(s) -

Kristina Chen,

Elvira O. Gosmanova,

Gary C. Curhan,

Markus Ketteler,

Mishaela R. Rubin,

Elyse Swallow,

Jing Zhao,

Jessie Wang,

Nicole Sherry,

Alan Krasner,

John P. Bilezikian

Publication year - 2020

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/clinem/dgaa490

Subject(s) - medicine , hypoparathyroidism , cohort , renal function , vitamin d and neurology , endocrinology , retrospective cohort study , parathyroid hormone , urology , calcium

Chronic hypoparathyroidism (HypoPT) is conventionally managed with oral calcium and active vitamin D. Recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) is a therapy targeting the pathophysiology of HypoPT by replacing parathyroid hormone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research